Literature DB >> 21666497

Moderate environmental enrichment mitigates tauopathy in a neurofibrillary tangle mouse model.

Inbal Lahiani-Cohen1, Athanasios Lourbopoulos, Ester Haber, Lea Rozenstein-Tsalkovich, Oded Abramsky, Nikolaos Grigoriadis, Hanna Rosenmann.   

Abstract

Epidemiological studies show that stimulating activities reduce the risk of dementia. In animal models of Alzheimer disease, there have been conflicting results of the effects of environmental enrichment (EE) on disease-related amyloid pathology. Here, we tested the direct effect of EE, independently of amyloid pathology, on brain neurofibrillary tangles (NFTs), which best correlate with dementia. We exposed transgenic mice (E257K/P301S-Tau-Tg driven by the natural tau promoter) to moderate nonstrained EE or regular environment. Concomitant with neurogenesis, we detected a decrease in NFT burden and a decrease in the activation of microglia in EE versus regular-environment mice. There was also a trend toward improvement in cognitive tasks in the EE mice. Increased immunoreactivity of brain-derived neurotrophic factor, which is involved in the regulation of tau phosphorylation, was detected in the EE mice, suggesting its possible involvement in the beneficial effects on NFTs and other parameters in the EE mice. These results suggest that NFTs may be directly responsive to environmental stimulating activities and that even nonstrained activities may mitigate tauopathies independent of the involvement of amyloid.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21666497     DOI: 10.1097/NEN.0b013e318221bfab

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  9 in total

Review 1.  Is Alzheimer's Disease Risk Modifiable?

Authors:  Alberto Serrano-Pozo; John H Growdon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  MEF2 is a key regulator of cognitive potential and confers resilience to neurodegeneration.

Authors:  Scarlett J Barker; Ravikiran M Raju; Noah E P Milman; Jun Wang; Jose Davila-Velderrain; Fatima Gunter-Rahman; Cameron C Parro; P Lorenzo Bozzelli; Fatema Abdurrob; Karim Abdelaal; David A Bennett; Manolis Kellis; Li-Huei Tsai
Journal:  Sci Transl Med       Date:  2021-11-03       Impact factor: 19.319

3.  Late-onset dementia: a mosaic of prototypical pathologies modifiable by diet and lifestyle.

Authors:  Mark P Mattson
Journal:  NPJ Aging Mech Dis       Date:  2015-09-28

Review 4.  The role of cognitive activity in cognition protection: from Bedside to Bench.

Authors:  Bin-Yin Li; Ying Wang; Hui-Dong Tang; Sheng-Di Chen
Journal:  Transl Neurodegener       Date:  2017-03-28       Impact factor: 8.014

5.  Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer's Disease.

Authors:  Marta Balietti; Cinzia Giuli; Patrizia Fattoretti; Paolo Fabbietti; Roberta Papa; Demetrio Postacchini; Fiorenzo Conti
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Exposure to 3-Nitropropionic Acid Mitochondrial Toxin Induces Tau Pathology in Tangle-Mouse Model and in Wild Type-Mice.

Authors:  Inbal Lahiani-Cohen; Olga Touloumi; Roza Lagoudaki; Nikolaos Grigoriadis; Hanna Rosenmann
Journal:  Front Cell Dev Biol       Date:  2020-01-14

Review 7.  Impairments in Brain Bioenergetics in Aging and Tau Pathology: A Chicken and Egg Situation?

Authors:  Amandine Grimm
Journal:  Cells       Date:  2021-09-24       Impact factor: 6.600

8.  Environmental enrichment extends photoreceptor survival and visual function in a mouse model of retinitis pigmentosa.

Authors:  Ilaria Barone; Elena Novelli; Ilaria Piano; Claudia Gargini; Enrica Strettoi
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

9.  Cognitive Intervention As an Early Non-pharmacological Strategy in Alzheimer's Disease: A Translational Perspective.

Authors:  Sarah W Gehres; Andreia Rocha; Antoine Leuzy; Cássio M Loss; Giordano G Viola; Eduardo R Zimmer
Journal:  Front Aging Neurosci       Date:  2016-11-29       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.